Evangelisches Krankenhaus Bethesda Mönchengladbach

Recent papers from Evangelisches Krankenhaus Bethesda Mönchengladbach

1. The impact of unilateral endometriomas on ovarian response to stimulation: a systematic review and meta-analysisHuman Reproduction · 2026
2. AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer—2026 UpdateThe Breast · 2026
3. Survival Analysis of the WSG TP-II Trial: Neoadjuvant Trastuzumab and Pertuzumab Plus Endocrine Therapy Versus Chemotherapy in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Positive Early Breast CancerJournal of Clinical Oncology · 2026
4. AGO Breast Committee recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2026European Journal of Surgical Oncology · 2026
5. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026Breast Care · 2026
6. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2026.2026
7. Abstract PD11-01: Development of a Multi-Modal Artificial Intelligence (MMAI) Model for Predicting Distant Metastasis in HR+ Early-Stage Invasive Breast CancerClinical Cancer Research · 2026
8. Integrative analysis of RNA expression signatures and recurrent genomic alterations before treatment: link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancerESMO Open · 2025
9. AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025European Journal of Surgical Oncology · 2025
10. Integrative analysis of pre-treatment RNA expression signatures and recurrent genomic alterations: Link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancer2025
11. 189O Ribociclib + endocrine treatment vs SoC chemotherapy in intermediate risk HR+/HER2- early breast cancer: Results from the neoadjuvant cohort of the phase-III WSG ADAPTcycle – trialESMO Open · 2025
12. AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2025Breast Care · 2025
13. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2025Breast Care · 2025
14. TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapyAnnals of Oncology · 2024
15. Determination of Quality Indicators for Microvascular Grafts in Cranio-Maxillofacial Surgery—A Retrospective Analysis of 251 Free FlapsJournal of Personalized Medicine · 2024
16. Palbociclib: Randomized Studies and Real-world Evidence as the Basis for Therapeutic Planning in Metastatic Breast CancerGeburtshilfe und Frauenheilkunde · 2024
17. Profiles of Geriatric Syndromes and Resources in Older Patients with Atrial FibrillationJournal of Clinical Medicine · 2024
18. Surgical Treatment of Patients with Endometriosis in the Certified Endometriosis Centers of the DACH Region – A Subanalysis of the Quality Assurance Study QS ENDO pilotGeburtshilfe und Frauenheilkunde · 2024
19. Neoadjuvant dynamic marker-adjusted personalized therapy comparing trastuzumab-deruxtecan versus pacli-/docetaxel + carboplatin + trastuzumab + pertuzumab in HER2+ early breast cancer: WSG-ADAPT-HER2-IV.Journal of Clinical Oncology · 2024
20. 193P Efficacy of sacituzumab govitecan versus treatment of physician’s choice in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: A meta-analysis of TROPiCS-02 and EVER-132-002 trialsESMO Open · 2024